Patient advocates hope Dr. Michelle Tarver will lead the agency to focus more on safety and less on rapid approvals. By Christina Jewett The Food and Drug Administration on Tuesday announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback